Long-term tracking of adults with type 2 diabetes
Official title: Cohort Study of Patients With Type 2 Diabetes
Run by National Taiwan University Hospital · NCT07245082 · Data updated 2026-11-12
This project will see if tracking metabolic, nutritional, and physical-function measures over time in adults with type 2 diabetes can identify risk factors to guide more personalized care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei, Zhongzheng Dist) |
| Status | Recruiting |
| Started | October 9, 2025 |
| Main results expected | August 21, 2028 |
| Study ends | August 21, 2028 |
| Registry record updated | September 15, 2026 |
| Trial ID | NCT07245082 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with a diagnosis of type 2 diabetes who can give informed consent and complete basic physical and nutritional assessments are ideal.
✕Probably not a fit
People who cannot understand the study, cannot cooperate with assessments, or are judged clinically unsuitable are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort combines retrospective and prospective patients with type 2 diabetes to enable long-term follow-up of metabolic markers, complications (such as cardiovascular disease, nephropathy, and neuropathy), and changes in nutritional status and physical function. Participants will undergo basic assessments including dietary habit surveys, body composition, waist and weight measurements, and grip strength, with data collected at baseline and during periodic follow-ups. The study aims to link these measures to clinical outcomes and to identify risk factors that influence disease progression. Findings are intended to inform individualized treatment decisions and integrated care strategies within the Taiwanese clinical setting.
Why it matters
Potential benefit: If successful, the findings could help clinicians personalize treatments and prevent complications by identifying modifiable risk factors.
How similar studies have gone: Large observational cohorts of type 2 diabetes have previously identified important risk factors, and this study builds on that by focusing on nutritional status and physical function in a Taiwanese population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults aged 18 or older. 2. Patients diagnosed with type 2 diabetes (based on medical history, diagnostic code, or use of hypoglycemic medication). 3. Participants are willing to participate in the study and have signed the consent form. 4. Participants are able to complete basic assessments (e.g., height, weight, waist circumference, grip strength, body composition, etc.). Exclusion Criteria: 1. Individuals who cannot understand the study content. 2. Individuals who cannot cooperate with relevant assessments. 3. Other individuals who are clinically deemed unsuitable for participation by the project leader.
Where it's running
-
National Taiwan University Hospital
Taipei, Zhongzheng Dist, Taiwan Recruiting
Study contacts
- Study coordinator: Chia-Wen Lu, Present Professor
- Email: biopsycosocial@gmail.com
- Phone: 886-2-23123456
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Proliverenol for liver fat and insulin resistance in type 2 diabetes
This study tests whether adding Proliverenol to standard diabetes care can improve liver fat and blood sugar control in adults with type 2 diabetes.
-
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.
-
Safety test of NNC9836-0001 in adults with overweight/obesity or type 2 diabetes
This study tests whether the new medicine NNC9836-0001 is safe and tolerable in adults who are overweight or have type 2 diabetes, compared to placebo.
-
RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes
This study tests the accuracy and safety of the RIGHTEST iFree 2 continuous glucose monitor in pregnant adults with type 1, type 2, or gestational diabetes.
-
EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes
This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.
-
Maridebart cafraglutide vs. semaglutide for type 2 diabetes on metformin
This trial tests whether maridebart cafraglutlide is as good as semaglutide at improving blood sugar in adults with type 2 diabetes who take metformin (with or without an SGLT-2 inhibitor).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.